HRT Financial’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,479,417
Closed -$8.8M – 4347
2026
Q1
$8.8M Buy
3,479,417
+2,435,672
+233% +$6.24M 0.02% 672
2025
Q4
$3.49M Buy
1,043,745
+948,891
+1,000% +$3.37M 0.01% 965
2025
Q3
$363K Sell
94,854
-871,969
-90% -$3.66M ﹤0.01% 2065
2025
Q2
$4.16M Buy
966,823
+825,123
+582% +$3.32M 0.02% 611
2025
Q1
$556K Sell
141,700
-29,138
-17% -$138K ﹤0.01% 1412
2024
Q4
$867K Buy
+170,838
New +$984K ﹤0.01% 1139
2024
Q3
– Sell
-623,918
Closed -$3.55M – 2513
2024
Q2
$3.55M Buy
+623,918
New +$3.98M 0.02% 512
2024
Q1
– Sell
-208,019
Closed -$1.93M – 2408
2023
Q4
$1.93M Buy
+208,019
New +$1.54M 0.01% 665
2023
Q3
– Sell
-209,550
Closed -$2M – 2468
2023
Q2
$2M Buy
+209,550
New +$1.78M 0.02% 611
2022
Q4
– Sell
-73,052
Closed -$685K – 2544
2022
Q3
$685K Buy
+73,052
New +$925K 0.01% 1249

Other funds holding CLVT

HRT Financial's CLVT Position: Q2 2026 in Review

HRT Financial sold out of Clarivate (CLVT) in Q2 2026, closing a stake of 3,479,417 shares — an estimated $8.8M sold.

HRT Financial first reported a position in CLVT in Q3 2022 and held it in 10 quarters. The position peaked at $8.8M in Q1 2026. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • HRT Financial reported no remaining Clarivate position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 3,479,417 Clarivate shares in Q2 2026, an estimated $8.8M.
  • HRT Financial first reported a position in Clarivate in Q3 2022 and held it in 10 quarters.
  • HRT Financial's Clarivate position peaked at $8.8M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.